| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, WEL224, Harvard Medical School, Boston, Massachusetts 02114
A marked effect of charge modification on the uptake and phototoxicity of a photoimmunoconjugate (PIC) was demonstrated. A site-specific conjugation strategy was developed to attach the photosensitizer chlorine6 (ce6) to the F(ab')2 fragment of the murine antiovarian cancer monoclonal antibody OC125. Poly-L-lysine linkers carrying ce6 with a cationic charge or by polysuccinylation with an anionic charge were used and covalently attached to partially reduced antibody via a heterobifunctional reagent. PICs were purified by column chromatography and were also radiolabeled with 125I. PIC binding and uptake were studied with a human ovarian cancer cell line, NIH-OVCAR-5, and a nonantigen-expressing colon cancer cell line, SW1116, and the data were compared with the binding and uptake of nonspecific rabbit IgG PICs. PICs with both cationic and anionic charges preserved antigen binding as shown by competition studies with native antibody, but the cationic PIC had up to 17 times higher cellular uptake of ce6, probably due to enhanced internalization. The ratio of ce6 to 125I retained by the cells varied with the likelihood of internalization and lysosomal degradation. The phototoxicity of the PICs generally varied with their uptake, but a correlation was found between lysosomal hydrolysis as measured by an increased cellular ratio of ce6:125I and increased relative phototoxicity. These data suggest cationic PICs may have advantages for photoimmunotherapy of disseminated intracavity cancer following local administration.
1 This work was supported by NIH Grant RO1 AR40352 and in part by the Department of Defense Free Electron Laser Program facilities.
2 To whom requests for reprints should be addressed. Phone: (617) 726-6996; Fax: (617) 726-3192.
Received 5/ 8/96. Accepted 9/16/96.
This article has been cited by other articles:
![]() |
M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin, and T. Hasan Pegylation of a Chlorine6 Polymer Conjugate Increases Tumor Targeting of Photosensitizer Cancer Res., October 1, 2001; 61(19): 7155 - 7162. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Soukos, M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch, and T. Hasan Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer in Vivo Cancer Res., June 1, 2001; 61(11): 4490 - 4496. [Abstract] [Full Text] [PDF] |
||||
![]() |
Marco Del Governatore, M. R. Hamblin, C. R. Shea, I. Rizvi, K. G. Molpus, K. K. Tanabe, and T. Hasan Experimental Photoimmunotherapy of Hepatic Metastases of Colorectal Cancer with a 17.1A Chlorine6 Immunoconjugate Cancer Res., August 1, 2000; 60(15): 4200 - 4205. [Abstract] [Full Text] |
||||
![]() |
J. Khadem, A. A. Veloso Jr, F. Tolentino, T. Hasan, and M. R. Hamblin Photodynamic Tissue Adhesion with Chlorine6 Protein Conjugates Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3132 - 3137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Duska, M. R. Hamblin, J. L. Miller, and T. Hasan Combination Photoimmunotherapy and Cisplatin: Effects on Human Ovarian Cancer Ex Vivo J Natl Cancer Inst, September 15, 1999; 91(18): 1557 - 1563. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |